By JHVEPhoto / Shutterstock.com

FDA Is Leaving Lab Employees At Risk of COVID-19 Exposure

An office created in 2016 to ensure safety at labs has never been given the authorities necessary to do its job, GAO says.

The Trump administration is failing to provide adequate oversight to ensure employees at some federal laboratories are safe from COVID-19 and other dangerous pathogens, according to a watchdog report released on Thursday. 

The Food and Drug Administration has yet to properly stand up a safety review office it created to address issues first identified in 2014, the Government Accountability Office found, creating safety risks in the midst of a global pandemic in which the agency is on the forefront of response efforts. FDA’s Office of Lab Safety lacks independence, proper authority, permanent staffing for inspections and agency-wide buy in, GAO said, preventing it from doing the job it was created to do.    

“Until FDA fully addresses the challenges we identified, the integrity of FDA’s laboratory safety program and the agency’s ability to ensure the safety of laboratory personnel and prevent the accidental release of hazardous biological agents—such as the virus that causes COVID-19— will continue to be at risk,” the auditors said. 

FDA launched the lab safety office to serve as “the central point of accountability for laboratory science and safety across the agency,” after officials discovered decades-old vials of smallpox in a storage room in 2014. The agency announced the office’s creation in 2016, but did not formally stand it up until early 2017. Its mission was to standardize safety practices at FDA’s 2,400 labs across 56 facilities and to provide oversight to ensure compliance with those standards. 

While the Office of Lab Safety has taken some steps toward that goal by issuing guidance documents to standardize safety protocols, improving incident reporting of “near misses” and boosting safety training, GAO found that FDA has failed to clearly spell out the agency’s goals, address fragmentation and duplication and sustain the attention of leadership. 

FDA officials who spoke to GAO took issue with the Office of Lab Safety’s roles, with facility directors saying the office’s jurisdiction should not include lab quality management or inspections. They said the office was wasting money and added no value to FDA’s mission. Other government inspectors could handle the safety office’s tasks, they told GAO, though the auditors said some overlap would help ensure no safety violations slipped through the cracks. 

“Without resolving disagreements over [the office's] roles and responsibilities, addressing issues of duplication, overlap and fragmentation, and identifying how leadership will sustain communication about laboratory safety reforms,” GAO said, “FDA will be unable to ensure that [the office] can successfully oversee the agency’s laboratory safety program.”

Specifically, the Office of Lab Safety has limited authority to conduct investigations and reviews as it cannot conduct unannounced visits. Pre-announced inspections give FDA labs time to clean up and fix problems before the review takes place, GAO said. The office also sits below site directors in the organization chart, risking its independence and stymying its ability to actually enforce compliance with the safety policies it creates. In some cases, GAO found, safety office officials were denied entry to FDA labs altogether. 

The Office of Lab Safety is also facing a funding crisis. President Trump slashed his request for the office in half in fiscal 2020 to just $2.5 million. Its funding has fluctuated since its creation, meaning the office has not been able to hire any permanent inspectors and currently has none on staff. 

GAO recommended that FDA resolve disagreements within its ranks and address duplication and overlap. It also told the agency to improve communications, boost the safety office's oversight authorities and identify independent funding streams for the office. The Health and Human Services Department said it agreed with GAO and would address its suggestions as quickly as possible. FDA has been on the forefront of approving therapeutics and vaccines for the novel coronavirus.

FDA Commissioner Stephen Hahn said he has launched a working group to examine his agency's safety program and potentially reorganize reporting structures. Hahn said FDA is "committed to ensuring laboratory safety to protect our personnel and their research" and that OLS plays an important role in that effort. He added FDA will draw from GAO's recommendations and the findings from its own review to update the OLS strategic plan. 

"Throughout the past months, as our agency has responded to the COVID-19 pandemic, I have seen the pivotal role many of our laboratories have played in responding, and I’m committed to ensuring that our laboratories continue to have the full support of FDA leadership to maintain this high level of excellence," Hahn said. "Safety and a commitment to scientific excellence remain at the core of the FDA’s mission and guide our work at our scientific research and analytical facilities and across all of our programs."

GAO noted FDA employees may remain at risk of dangerous exposures.

“Effective oversight of laboratories that work with dangerous pathogens is essential to preventing the release of hazardous biological agents that could expose laboratory employees and the public to serious and potentially lethal infections,” GAO said. “FDA must ensure that its laboratory safety program is effectively overseen in order to prevent such an occurrence.”

This story was updated with additional comment.

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.